In the EU project “EVIDENT”, scientists investigated around 180 patient samples from the Ebola epidemic in West Africa, to elucidate the origin of the epidemic in the individual countries and the
DZIF researchers at the LMU Munich have successfully tested their candidate vaccine against MERScoronavirus in a preclinical trial. Plans for a clinical trial, in which the virus will be tested in
The German Center for Infection Research (DZIF) has been playing a significant role in one of five new African-German research networks. Under the name “TB-Sequel”, the BMBF has been funding research
According to figures of the World Health Organization, some 8.7 million people contracted tuberculosis in 2012 and this disease is fatal for approximately 1.3 million people throughout the world each
Researchers at the University of Bonn and the German Center for Infection Research (DZIF) have discovered two new groups of viruses within the Bunyavirus family in the tropical forest of Ivory Coast
In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded
The DZIF has initiated an online consultation service for treating cases of multidrug-resistant tuberculosis. Here, doctors can submit their cases and get advice for further treatment from experts at
30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome AIDS, and despite intensive research, no vaccine or cure has yet been found. An international team of
The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available. At the Hamburg-Eppendorf University Medical Center (UKE), in Geneva
PanACEA, the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics, presented the results of its most recent phase IIb study. The most exciting finding from the study is that high
